PureTech Health (PRTC) Return on Assets (2023 - 2025)

PureTech Health (PRTC) reported Return on Assets of 0.0% for Q4 2025, little changed year-over-year from 0.0% in Q4 2024, and down 4.97% quarter-over-quarter from 0.0% in Q2 2025.

PureTech Health (PRTC) Return on Assets (2023 - 2025) Analysis & Trends

PureTech Health (PRTC) has 3 years of Return on Assets data on file, last reported at 0.0% in Q4 2025.

  • Return on Assets for Q4 2025 came in at 0.0%, changed 0.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.0% (changed 0.0% YoY), and the FY2025 annual result was 0.0%, changed 0.0% from the prior year.
  • Return on Assets fell to 0.0% in Q4 2025 per PRTC's latest filing, from 0.0% in the prior quarter.
  • Over five years, Return on Assets peaked at 0.0% in Q4 2023 and troughed at 0.0% in Q4 2025.
  • A 3-year average of 0.0% and a median of 0.0% in 2024 frame the typical range for Return on Assets.
  • On a YoY basis, Return on Assets climbed as much as 0 bps in 2024 and fell as far as 0 bps in 2024.
  • A 3-year view of Return on Assets shows it stood at 0.0% in 2023, then slumped by 7103 bps to 0.0% in 2024, then plunged by 46 bps to 0.0% in 2025.
  • Business Quant data shows PRTC's Return on Assets at 0.0% in Q4 2025, 0.0% in Q2 2025, and 0.0% in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Alterity Therapeutics 821,726.73 Bn 821,726.69 Bn - -
2 Belite Bio 57,768.00 Bn 57,768.00 Bn - -0.80%
3 Quantum Biopharma 16,655.88 Bn 16,655.88 Bn - -0.01%
4 Legend Biotech 3,540.00 Bn 3,539.71 Bn 242.10 Mn 0.00%
5 Evaxion A 1,526.26 Bn 1,526.24 Bn - 0.00%
6 Akari Therapeutics 1,520.09 Bn 1,520.09 Bn - -0.01%
7 Psyence Biomedical 223.87 Bn 223.87 Bn - 0.00%
8 Vertex Pharmaceuticals 114.47 Bn 107.23 Bn 2.59 Bn 0.00%
9 Abivax 91.22 Bn 91.22 Bn - -0.01%
10 PureTech Health 86.36 Mn -190.94 Mn - 0.00%

Historic Data

Download Data
DateValue
Dec 31, 2025 0.00%
Jun 30, 2025 0.00%
Dec 31, 2024 0.00%
Jun 30, 2024 0.00%
Dec 31, 2023 0.00%